Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.9152
+0.0462 (5.32%)
Jun 1, 2026, 2:09 PM EDT - Market open
Tenaya Therapeutics Employees
Tenaya Therapeutics had 70 employees as of December 31, 2025. The number of employees decreased by 27 or -27.84% compared to the previous year.
Employees
70
Change (1Y)
-27
Growth (1Y)
-27.84%
Revenue / Employee
$3,214
Profits / Employee
-$1,185,786
Market Cap
198.60M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 70 | -27 | -27.84% |
| Dec 31, 2024 | 97 | -43 | -30.71% |
| Dec 31, 2023 | 140 | -1 | -0.71% |
| Dec 31, 2022 | 141 | 35 | 33.02% |
| Sep 30, 2022 | 140 | 40 | 40.00% |
| Jun 30, 2022 | 135 | 50 | 58.82% |
| Mar 31, 2022 | 125 | 50 | 66.67% |
| Dec 31, 2021 | 106 | 31 | 41.33% |
| Sep 30, 2021 | 100 | 25 | 33.33% |
| Jun 30, 2021 | 85 | - | - |
| Mar 31, 2021 | 75 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tonix Pharmaceuticals Holding | 142 |
| MediWound | 121 |
| Precision BioSciences | 66 |
| Acumen Pharmaceuticals | 61 |
| Korro Bio | 49 |
| Milestone Pharmaceuticals | 38 |
| Enlivex | 34 |
| Q32 Bio | 22 |
TNYA News
- 3 days ago - Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026 - GlobeNewsWire
- 17 days ago - Tenaya Therapeutics Transcript: Study update - Transcripts
- 17 days ago - Tenaya Therapeutics Press release: Study update - Filings
- 17 days ago - Tenaya Therapeutics Slides: Study update - Filings
- 17 days ago - Tenaya reports data from RIDGE-1 Phase 1b/2 clinical trial of TN-401 - TheFly
- 17 days ago - Positive Interim Data from Cohorts 1 and 2 of Tenaya's RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Demonstrated Consistent Reductions in Arrhythmia Burden for Adults with PKP2-associated ARVC - GlobeNewsWire
- 25 days ago - Tenaya Therapeutics reports Q1 EPS (9c), consensus (9c) - TheFly
- 25 days ago - Tenaya Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire